Jun 19 2013, 2:32am CDT | by Luigi Lugmayr
"We only managed to broaden the flu vaccination range because 90 percent of vaccines are
already produced in Brazil," he said.
Brazil also announced 27 partnerships with public and private labs to produce biopharmaceuticals, including an allergy vaccine, a growth hormone, a cicatrizing drug, and medications to treat cancer, arthritis and diabetes.
Through the partnerships, Brazil expects to produce a total of 25 biopharmaceutical drugs.
Padilha hailed the advances in drug production, saying that just "two years ago, the country did not produce insulin or biopharmaceuticals for cancer and inflammatory diseases".
The Brazil-made vaccines will be made possible thanks to French company Sanofi Pasteur transferring the technology to Brazil's Butantan Institute, in Sao Paulo.
H1N1 cases emerged across world again this year after a 2009 pandemic of the virus that killed 20,000 people in several countries.
Luigi is the founding Chief Editor of I4U News and brings over 15 years experience in the technology field to the ever evolving and exciting world of gadgets. He started I4U News back in 2000 and evolved it into vibrant technology magazine.
Luigi can be contacted directly at firstname.lastname@example.org. Luigi posts regularly on LuigiMe.com about his experience running I4U.
blog comments powered by Disqus